➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

AstraZeneca
Dow
Medtronic
Colorcon
Mallinckrodt
McKinsey

Last Updated: January 25, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Asimadoline

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the drug development status for Asimadoline?

Asimadoline is an investigational drug.

There have been 7 clinical trials for Asimadoline. The most recent clinical trial was a Phase 3 trial, which was initiated on May 1st 2010.

The most common disease conditions in clinical trials are Syndrome, Irritable Bowel Syndrome, and Diarrhea. The leading clinical trial sponsors are Tioga Pharmaceuticals, RTI Health Solutions, and Mayo Clinic.

Recent Clinical Trials for Asimadoline
TitleSponsorPhase
Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic DermatitisTioga PharmaceuticalsPhase 2
A Metabolite Identification, Mass Balance, and PK Study of [14C]-Asimadoline to Healthy Adult Male VolunteersTioga PharmaceuticalsPhase 1
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)RTI Health SolutionsPhase 3

See all Asimadoline clinical trials

Clinical Trial Summary for Asimadoline

Top disease conditions for Asimadoline
Top clinical trial sponsors for Asimadoline

See all Asimadoline clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Dow
Medtronic
Colorcon
Mallinckrodt
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.